POC Coagulation Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

POC Coagulation Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : August, 2020 | Medical Devices | PPT format

Report Digest

Global POC Coagulation Testing Market: Overview

Point of care coagulation or POC coagulation testing analyzers measures the prothrombin time. These are self-testing machines that are used by the patients at home to test their prothrombin levels. Prevalence of a broad range of blood disorders has led to the development of cardiovascular co-morbidities in patients. They are often prescribed anti-thrombotic drugs to prevent the onset of severe events such as a sudden increase in the level of blood coagulation. POC coagulation testing helps the patients to monitor such incidences and keep things in check. This testing is generally popular among patients suffering from cardiovascular disorders and those who undergo cardiovascular surgeries such as angioplasty and cardiac bypass among others.

Global POC Coagulation Testing Market: Notable Developments

Some of the key developments that have influenced the global POC coagulation testing market in recent years:

  • Recently, Siemens Healthcare AG launched a new product called Xprecia Stride Coagulation Analyzer. This product offers primary and urgent care and is highly reliable for the PT/INR testing for oral anticoagulation therapy. The company claims this POC coagulation testing device can deliver lab accuracy.
  • In August 2019, Siemens Healthcare AG announced that the company is well placed to acquire Corindus, a forerunner in the robotic-assisted vascular interventions. This takeover is strategically important for Siemens Healthcare to enhance its Advanced Therapies business including its foothold in the POC coagulation testing market. The overall value of the deal is expected to be around US$1.1 billion.
  • In February 2019, a key player in the global POC coagulation testing market, Danaher, announced that it has acquired the biopharma business of GE Life Sciences. The overall value of the deal is around US$21.4 billion. This acquisition is expected to significantly transform the strengths of Danaher in terms of its product development, research, and manufacturing0020workflows.

Global POC Coagulation Testing Market: Drivers and Restraints

There is a wide array of factors that are influencing a positive growth of the global POC coagulation testing market. Some of them are mentioned below:

  • Faster Results: The whole point of development of POC products is to reduce the turn-around time. It is especially important in cases of cardiovascular disorders. With these devices, patients get faster results and are better equipped to monitor their and act in case of any emergency. This is thus driving the uptake of the POC coagulation testing market.
  • Automatic data Uploading: Another important feature that is upscaling the popularity of the global POC coagulation testing market is the automatic uploading of data. Patients don’t have to worry about the manual login and entering the data (that has chances of errors).
  • Increasing demand: There has been a growing demand for such POC coagulation testing devices across the globe especially for pre-operative and post-operative screening. This is also fueling the growth of the market.

Global POC Coagulation Testing Market: Geographical Outlook

The global POC coagulation testing market is segmented into key areas such as North America, Asia Pacific, Latin America, the Middle East and Africa, and Europe. Of these, the global market is expected to be dominated by North America region in the coming years. This is because of the swift availability of latest products, highly developed healthcare infrastructure, and growing awareness among patients. The Asia Pacific segments are projected to show a considerable rate of growth during the forecast period due to the presence of developing economies that are working to strengthen their healthcare and pharma sector.

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.